UI-018

N/A

Report date: 2024/11/26 20:00:06
NME

Base Information

Drug NameUI-018
Drug Alias NameUI-018
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLipid modulators
TargetsLipid
Therapy Area/IndicationsHyperlipidemias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKorea United Pharm Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKorea United Pharm Inc
Active IndicationsN/A
Inactive IndicationsHyperlipidemias

Other Information

ATC CodeN/A
Related LinksN/A